These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 11564824)

  • 1. Characterization of mutations, including a novel regulatory defect in the first intron, in Bruton's tyrosine kinase gene from seven Korean X-linked agammaglobulinemia families.
    Jo EK; Kanegane H; Nonoyama S; Tsukada S; Lee JH; Lim K; Shong M; Song CH; Kim HJ; Park JK; Miyawaki T
    J Immunol; 2001 Oct; 167(7):4038-45. PubMed ID: 11564824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point mutation in intron 11 of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia.
    Shinomiya N; Kanegane H; Watanabe A; Yamaguchi Y; Futatani T; Miyawaki T
    Pediatr Int; 2000 Dec; 42(6):689-92. PubMed ID: 11192530
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemia.
    Saha BK; Curtis SK; Vogler LB; Vihinen M
    Mol Med; 1997 Jul; 3(7):477-85. PubMed ID: 9260159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulatory elements within the first intron of Bruton's tyrosine kinase.
    Rohrer J; Conley ME
    Blood; 1998 Jan; 91(1):214-21. PubMed ID: 9414287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan.
    Hashimoto S; Tsukada S; Matsushita M; Miyawaki T; Niida Y; Yachie A; Kobayashi S; Iwata T; Hayakawa H; Matsuoka H; Tsuge I; Yamadori T; Kunikata T; Arai S; Yoshizaki K; Taniguchi N; Kishimoto T
    Blood; 1996 Jul; 88(2):561-73. PubMed ID: 8695804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia.
    Brooimans RA; van den Berg AJ; Rijkers GT; Sanders LA; van Amstel JK; Tilanus MG; Grubben MJ; Zegers BJ
    J Med Genet; 1997 Jun; 34(6):484-8. PubMed ID: 9192269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of germline mutations of the gene encoding Bruton's tyrosine kinase in families with X-linked agammaglobulinemia.
    Hagemann TL; Rosen FS; Kwan SP
    Hum Mutat; 1995; 5(4):296-302. PubMed ID: 7627183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
    Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
    J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course.
    Holinski-Feder E; Weiss M; Brandau O; Jedele KB; Nore B; Bäckesjö CM; Vihinen M; Hubbard SR; Belohradsky BH; Smith CI; Meindl A
    Pediatrics; 1998 Feb; 101(2):276-84. PubMed ID: 9445504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulatory defects in the first intron of Bruton's tyrosine kinase.
    Shin DM; Jo EK; Kanegane H; Futatani T; Zhao M; Song CH; Yamagishi A; Miyawaki T
    Pediatr Int; 2008 Dec; 50(6):801-5. PubMed ID: 19067895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of mutations in the Bruton's tyrosine kinase gene, including a novel genomic rearrangements resulting in large deletion, in Korean X-linked agammaglobulinemia patients.
    Jo EK; Wang Y; Kanegane H; Futatani T; Song CH; Park JK; Kim JS; Kim DS; Ahn KM; Lee SI; Park HJ; Hahn YS; Lee JH; Miyawaki T
    J Hum Genet; 2003; 48(6):322-326. PubMed ID: 12768435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia.
    Hagemann TL; Chen Y; Rosen FS; Kwan SP
    Hum Mol Genet; 1994 Oct; 3(10):1743-9. PubMed ID: 7880320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection.
    Futatani T; Miyawaki T; Tsukada S; Hashimoto S; Kunikata T; Arai S; Kurimoto M; Niida Y; Matsuoka H; Sakiyama Y; Iwata T; Tsuchiya S; Tatsuzawa O; Yoshizaki K; Kishimoto T
    Blood; 1998 Jan; 91(2):595-602. PubMed ID: 9427714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemia.
    Vorechovský I; Vihinen M; de Saint Basile G; Honsová S; Hammarström L; Müller S; Nilsson L; Fischer A; Smith CI
    Hum Mol Genet; 1995 Jan; 4(1):51-8. PubMed ID: 7711734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An exon-skipping mutation in the btk gene of a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency.
    Duriez B; Duquesnoy P; Dastot F; Bougnères P; Amselem S; Goossens M
    FEBS Lett; 1994 Jun; 346(2-3):165-70. PubMed ID: 8013627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of a novel mutation in the SRC homology domain 2 (SH2) of Bruton's tyrosine kinase and direct female carrier evaluation in a family with X-linked agammaglobulinemia.
    Schuster V; Seidenspinner S; Kreth HW
    Am J Med Genet; 1996 May; 63(1):318-22. PubMed ID: 8723128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.
    de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW
    Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinase mutant Btk results in atypical X-linked agammaglobulinaemia phenotype.
    Gaspar HB; Ferrando M; Caragol I; Hernandez M; Bertran JM; De Gracia X; Lester T; Kinnon C; Ashton E; Espanol T
    Clin Exp Immunol; 2000 May; 120(2):346-50. PubMed ID: 10792386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel Bruton's tyrosine kinase gene (BTK) invariant splice site mutation in a Malaysian family with X-linked agammaglobulinemia.
    Chear CT; Gill HK; Ramly NH; Dhaliwal JS; Bujang N; Ripen AM; Mohamad SB
    Asian Pac J Allergy Immunol; 2013 Dec; 31(4):320-4. PubMed ID: 24383975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase.
    Conley ME; Fitch-Hilgenberg ME; Cleveland JL; Parolini O; Rohrer J
    Hum Mol Genet; 1994 Oct; 3(10):1751-6. PubMed ID: 7849697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.